Role of Biomarkers in the Development of PARP Inhibitors

por Ganguly, Bratati, Dolfi, Sonia C., Rodriguez-Rodriguez, Lorna, Ganesan, Shridar, Hirshfield, Kim M.
Publicado 2016

Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers

por Paratala, Bhavna S., Dolfi, Sonia C., Khiabanian, Hossein, Rodriguez-Rodriguez, Lorna, Ganesan, Shridar, Hirshfield, Kim M.
Publicado 2016

Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs

por Dolfi, Sonia C., Jäger, Adriana V., Medina, Daniel J., Haffty, Bruce G., Yang, Jin-Ming, Hirshfield, Kim M.
Publicado 2014

P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanisms

por LIN, SIANG-YO, DOLFI, SONIA C., AMIRI, SOHRAB, LI, JAIDONG, BUDAK-ALPDOGAN, TULIN, LEE, KUO-CHIEH, DERENZO, CHRISTOPHER, BANERJEE, DEBABRATA, GLOD, JOHN
Publicado 2013

The metabolic demands of cancer cells are coupled to their size and protein synthesis rates

por Dolfi, Sonia C, Chan, Leo Li-Ying, Qiu, Jean, Tedeschi, Philip M, Bertino, Joseph R, Hirshfield, Kim M, Oltvai, Zoltán N, Vazquez, Alexei
Publicado 2013

Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells

por Dolfi, Sonia C, Medina, Daniel J, Kareddula, Aparna, Paratala, Bhavna, Rose, Ashley, Dhami, Jatinder, Chen, Suzie, Ganesan, Shridar, Mackay, Gillian, Vazquez, Alexei, Hirshfield, Kim M
Publicado 2017

Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells

por Tedeschi, P M, Markert, E K, Gounder, M, Lin, H, Dvorzhinski, D, Dolfi, S C, Chan, L L-Y, Qiu, J, DiPaola, R S, Hirshfield, K M, Boros, L G, Bertino, J R, Oltvai, Z N, Vazquez, A
Publicado 2013

Metabotropic Glutamate Receptor 1 Expression and Its Polymorphic Variants Associate with Breast Cancer Phenotypes

por Mehta, Madhura S., Dolfi, Sonia C., Bronfenbrener, Roman, Bilal, Erhan, Chen, Chunxia, Moore, Dirk, Lin, Yong, Rahim, Hussein, Aisner, Seena, Kersellius, Romona D., Teh, Jessica, Chen, Suzie, Toppmeyer, Deborah L., Medina, Dan J., Ganesan, Shridar, Vazquez, Alexei, Hirshfield, Kim M.
Publicado 2013

RET rearrangements are actionable alterations in breast cancer

por Paratala, Bhavna S., Chung, Jon H., Williams, Casey B., Yilmazel, Bahar, Petrosky, Whitney, Williams, Kirstin, Schrock, Alexa B., Gay, Laurie M., Lee, Ellen, Dolfi, Sonia C., Pham, Kien, Lin, Stephanie, Yao, Ming, Kulkarni, Atul, DiClemente, Frances, Liu, Chen, Rodriguez-Rodriguez, Lorna, Ganesan, Shridar, Ross, Jeffrey S., Ali, Siraj M., Leyland-Jones, Brian, Hirshfield, Kim M.
Publicado 2018

A functionally significant SNP in TP53 and breast cancer risk in African-American women

por Murphy, Maureen E., Liu, Song, Yao, Song, Huo, Dezheng, Liu, Qin, Dolfi, Sonia C., Hirshfield, Kim M., Hong, Chi-Chen, Hu, Qiang, Olshan, Andrew F., Ogundiran, Temidayo O., Adebamowo, Clement, Domchek, Susan M., Nathanson, Katherine L., Nemesure, Barbara, Ambs, Stefan, Blot, William J., Feng, Ye, John, Esther M., Bernstein, Leslie, Zheng, Wei, Hu, Jennifer J., Ziegler, Regina G., Nyante, Sarah, Ingles, Sue A., Press, Michael F., Deming, Sandra L., Rodriguez-Gil, Jorge L., Haiman, Christopher A., Olopade, Olufunmilayo I., Lunetta, Kathryn L., Palmer, Julie R., Ambrosone, Christine B.
Publicado 2017